<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Saudi Med</journal-id>
      <journal-id journal-id-type="publisher-id">ASM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Saudi Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0256-4947</issn>
      <issn pub-type="epub">0975-4466</issn>
      <publisher>
        <publisher-name>Medknow Publications</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19318755</article-id>
      <article-id pub-id-type="pmc">2813627</article-id>
      <article-id pub-id-type="publisher-id">ASM-29-156</article-id>
      <article-id pub-id-type="doi">10.4103/0256-4947.51795</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transverse myelitis as a presenting feature of late onset systemic lupus erythematosus</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Almoallim</surname>
            <given-names>Hani</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bukhari</surname>
            <given-names>Majidah</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alwafi</surname>
            <given-names>Leena</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wali</surname>
            <given-names>Gassan</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
      </contrib-group>
      <aff id="AF0001">King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia</aff>
      <author-notes>
        <corresp id="cor1">Correspondence: Hani Almoallim Consultant Rheumatologist, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia PO Box 1821 Jeddah 21441 Saudi Arabia T: +966-2-667-7777 ext. 5032 <email xlink:href="hanialmoallim@hotmail.com">hanialmoallim@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2009</year>
      </pub-date>
      <volume>29</volume>
      <issue>2</issue>
      <fpage>156</fpage>
      <lpage>157</lpage>
      <permissions>
        <copyright-statement>&#xA9; Annals of Saudi Medicine</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>To the Editor:</bold>
    </p>
    <p>Late-onset systemic lupus erythematosus (SLE) is the type of SLE whose manifestations reportedly begin after the age of 50<xref ref-type="bibr" rid="CIT1">1</xref>&#x2013;<xref ref-type="bibr" rid="CIT3">3</xref> or 65 years.<xref ref-type="bibr" rid="CIT4">4</xref> The prevalence of transverse myelitis (TM) in SLE patients is 1% to 2%.<xref ref-type="bibr" rid="CIT5">5</xref> It can occur as the initial manifestation of SLE in up to 39% of patients.<xref ref-type="bibr" rid="CIT5">5</xref> TM as a presenting feature of late-onset SLE is rare. Only a few cases have been reported.<xref ref-type="bibr" rid="CIT5">5</xref>&#x2013;<xref ref-type="bibr" rid="CIT7">7</xref> We report on a previously healthy 65-year-old female patient who presented to our hospital with a month-long history of progressive weakness, numbness of the lower limbs and unsteady gait that was associated with loss of bowel and bladder control. She also reported an intermittent history of fever but no weight loss, or night sweats, headache, vomiting or seizure activity. She was conscious, alert and oriented to place, person and time. Her temperature was 38.0&#xB0;C, heart rate 123 beats/minute, blood pressure 155/80 mm Hg and respiratory rate 18 per minute with 98% oxygen saturation. Examination of the cranial nerves was unremarkable. Motor examination showed hypotonia in the lower limbs with a power of 0/5, absent reflexes and downgoing planter responses bilaterally. There was loss of all sensation up to the nipples at the level of T4. Investigations at presentation showed neutrophilic leukocytosis with lymphopenia, an elevated PTT of 45 seconds<xref ref-type="bibr" rid="CIT1">1</xref> and an erythrocyte sedimentation rate of 5 seconds with normal renal and hepatic profiles. Cerebrospinal fluid (CSF) analysis showed pleocytosis; white blood cells (WBC) of 3.71&#xD7;10<sup>9</sup>/L with 75% lymphocytes, glucose of 5.5 mmol/L, protein of 1419 mg/L and negative cultures for all bacteria and viruses including acid fast bacilli. PCR for acid fast bacilli was negative as well. Urine culture was positive for <italic>E. coli.</italic> MRI of the spine and brain with T1-and T2-weighted sagittal and axial images including a magnetic resonance angiogram showed normal brain parenchyma and diffuse hyperintensity within the cord at the level of thoracic spine T1 extending up to T10. The diagnosis of idiopathic TM was made. She was treated with pulse therapy with IV methylprednisolone (1 gram) for 5 days and intravenous ceftriaxone. Her condition improved significantly with power increased from 0/5 to 3/5 in the lower limbs. Two weeks later, despite taking an oral steroid, power over her lower limbs was 0/5 again. The repeat MRI showed multifocal areas of significant hyperintensity within the thoracic spine with multifocal enhancement in the posterior aspect of the cord post gadolinium (<xref ref-type="fig" rid="F0001">Figure 1</xref>). Anti-tuberculosis medications were initiated and discontinued when acid fast bacilli were not isolated by cultures and PCR technique. Rheumatological assessment after approximately 1 month of hospital admission revealed a positive antinuclear antibody (ANA) test with a titer of 1:320. The antids DNA antibodies were repeatedly positive at 32.9 IU/mL (normal less than 10 IU/mL). Lupus anticoagulant was positive as well. She was diagnosed with TM as a presenting manifestation of SLE with antiphospholipid antibodies. Another pulse therapy with IV methylprednisolone (1 gram) for 5 days was started. The patient preferred not to receive any additional therapeutic interventions. Her weakness improved significantly with a power of almost 5/5 over limb girdle muscles 8 months after discharge. The repeat MRI demonstrated some improvement in previously present hyperintensity within the upper thoracic cord.</p>
    <fig id="F0001" position="float">
      <label>Figure 1</label>
      <caption>
        <p>MRI of the thoracic spine (sagittal view T1-weighted post-gadolinium image) showing some multifocal areas of enhancement within the cord that predominantly involve the posterior aspect of the cord (black arrows).There are also extensive focal small enhancing lesions (white arrows).</p>
      </caption>
      <graphic xlink:href="ASM-29-156-g001"/>
    </fig>
    <p>The management of TM continues to represent a major therapeutic challenge for clinicians in daily practice. The ideal drugs, doses, and the length of treatment are not yet well defined. In older studies, most patients were treated with IV corticosteroids alone, whereas more recently some centers prefer a more aggressive approach with IV methylprednisolone pulse therapy plus IV cyclophosphamide. There were no clear differences between these drugs in five cases of TM when both were studied against each other after induction therapy with methylprednisolone.<xref ref-type="bibr" rid="CIT8">8</xref> However, several studies reported good to fair functional outcomes with combined treatment.<xref ref-type="bibr" rid="CIT6">6</xref> The majority of TM cases reported in the literature were positive for antiphospholipid antibodies: 73% in one series<xref ref-type="bibr" rid="CIT6">6</xref> and 55% to 64% in another.<xref ref-type="bibr" rid="CIT5">5</xref> One of the strongest risk factors for the development of significant neuropsychiatric damage was the presence of antiphospholipid antibodies.<xref ref-type="bibr" rid="CIT9">9</xref> This has resulted in the introduction of anticoagulant therapy in the management of TM patients with positive antiphospholipid antibodies, but this practice remains controversial. Plasmapheresis has been used to complement this treatment regimen,<xref ref-type="bibr" rid="CIT5">5</xref><xref ref-type="bibr" rid="CIT10">10</xref><xref ref-type="bibr" rid="CIT11">11</xref> but it is still unclear if it has any additional therapeutic benefit. There are recent reports on the successful use of anti-CD20 in patients with TM.<xref ref-type="bibr" rid="CIT12">12</xref><xref ref-type="bibr" rid="CIT13">13</xref> The patient described in this letter had significant improvement with the use of steroids alone. TM in the elderly might be controlled with the use of a large dose of steroid.</p>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="CIT1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rovensky</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tuchynova</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Systemic lupus erythematosus in the elderly</article-title>
          <source>Autoimmun Rev</source>
          <year>2008</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>235</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">18190884</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karoubi Nordon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hayem</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mentres</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Palazzo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Legrain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Raveau</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Late-onset systemic lupus erythematosus: a new approach</article-title>
          <source>Lupus</source>
          <year>2007</year>
          <volume>16</volume>
          <issue>12</issue>
          <fpage>1011</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">18042600</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boddaert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huong</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Amoura</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wechsler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Godeau</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature</article-title>
          <source>Medicine (Baltimore)</source>
          <year>2004</year>
          <volume>83</volume>
          <issue>6</issue>
          <fpage>348</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">15525847</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pu</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>The clinical features and prognosis of lupus with disease onset at age 65 and older</article-title>
          <source>Lupus</source>
          <year>2000</year>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>96</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">10787005</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kovacs</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lafferty</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Brent</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>DeHoratius</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature</article-title>
          <source>Ann Rheum Dis</source>
          <year>2000</year>
          <volume>59</volume>
          <issue>2</issue>
          <fpage>120</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">10666167</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Mellor-Pita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Joven</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Allanson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies</article-title>
          <source>J Rheumatol</source>
          <year>2004</year>
          <month>2</month>
          <volume>31</volume>
          <issue>2</issue>
          <fpage>280</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">14760797</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Juan</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Longitudinal myelitis as an initial manifestation of systemic lupus erythematosus</article-title>
          <source>Am J Med Sci</source>
          <year>2004</year>
          <volume>327</volume>
          <issue>2</issue>
          <fpage>105</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">14770030</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barile-Fabris</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ariza-Andraca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Olgu&#xED;n-Ortega</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jara</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Fraga-Mouret</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Miranda-Lim&#xF3;n</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Fuentes de la Mata</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Alocer-Varela</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus</article-title>
          <source>Ann Rheum Dis</source>
          <year>2005</year>
          <month>4</month>
          <volume>64</volume>
          <issue>4</issue>
          <fpage>620</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">15769918</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanly</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Management of neuropsychiatric lupus</article-title>
          <source>Best Pract Res Clin Rheumatol</source>
          <year>2005</year>
          <volume>19</volume>
          <issue>5</issue>
          <fpage>799</fpage>
          <lpage>821</lpage>
          <pub-id pub-id-type="pmid">16150404</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitwalli</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Memon</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Abu-Aisha</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Al-Wakeel</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Tarif</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Askar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hammad</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Transverse myelitis in a patient with severe lupus nephritis: a case report</article-title>
          <source>Saudi J Kidney Dis Transpl</source>
          <year>2002</year>
          <season>Oct-Dec</season>
          <volume>13</volume>
          <issue>4</issue>
          <fpage>492</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">17660673</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimura</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Seino</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hirayama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Aramaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Amano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord</article-title>
          <source>Intern Med</source>
          <year>2002</year>
          <month>2</month>
          <volume>41</volume>
          <issue>2</issue>
          <fpage>156</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">11868606</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chehab</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Fischer-Betz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>[Anti-CD20 therapy for inducing and maintaining remission in refractory systemic lupus erythematosus]</article-title>
          <source>Z Rheumatol</source>
          <year>2007</year>
          <month>7</month>
          <volume>66</volume>
          <issue>4</issue>
          <fpage>328</fpage>
          <fpage>330</fpage>
          <lpage>6</lpage>
          <comment>German</comment>
          <pub-id pub-id-type="pmid">17440741</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armstrong</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>McCarron</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody)</article-title>
          <source>Rheumatol Int</source>
          <year>2006</year>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>77</fpage>
          <lpage>2</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
